Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ. [electronic resource]
Producer: 20181012Description: 61 p. digitalISSN:- 1546-0096
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Humans
- Kidney -- pathology
- Lupus Erythematosus, Systemic -- complications
- Mutation
- Pedigree
- Protein Kinase C-delta -- genetics
- Rituximab -- adverse effects
- Thrombocytopenia -- complications
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.